Peers for comparison



Key facts today


Azora Therapeutics (AZR) said its oral ulcerative-colitis drug AT177 remains in IND-enabling studies, with Phase 1 trials planned for the first half of 2027. It also formed a five-member board. 1 2
On Nov. 5, 2026, Azora Therapeutics (AZR) named a five-member board: CEO Matt Davidson and independent directors Wendy Young, Aida Habtezion, Thomas Soloway and Paul J. Hastings. 1
Analyze the impactAnalyze the impact
Market capitalization
‪10.63 M‬ USDNano cap
−16.54 USD
‪−7.98 M‬ USD
0.00 USD
Beta (1Y)
1.72
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
6
Change (1Y)
−1−14.29%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.33 M‬ USD

Company info


CEO
Matthew Davidson
Headquarters
Los Angeles
ISIN
US0548001074
CUSIP
054800107
FIGI
BBG00HNGDTR4
Identifiers
ISIN US0548001074
CFI code
ESVUFR
Azora Therapeutics, Inc. is a biopharmaceutical company that develops therapies for immune-mediated inflammatory diseases. Its investigational oral drug, AT177, is being develop for inflammatory bowel diseases, with an initial focus on ulcerative colitis. The company was founded by Julie Saiki and Matthew Davidson which is headquartered in Los Angeles, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Azora Therapeutics, Inc. is scheduled to release its next earnings report on Nov 18, 2026.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
AZR stock is 6.58% volatile and has beta coefficient of 1.72.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like AZR are typically less volatile than smaller companies

Track every detail on Azora Therapeutics, Inc. stock chart and check out the list of the most volatile stocks — is Azora Therapeutics, Inc. there?
To understand the AZR stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −1.98%
– 1 week — −11.78%
– 1 month — −9.36%

AZR all-time low was 1.31 USD (May 15, 2026), and its highest price is 5,900.00 USD (Jan 15, 2019). Find more dynamics in the Stock Heatmap and on the Azora Therapeutics, Inc. stock chart.
Azora Therapeutics, Inc. market capitalization is ‪10.63 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Azora Therapeutics, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Azora Therapeutics, Inc. stacks up against other companies
The safest way to buy Azora Therapeutics, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade AZR directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 5, 2026, the company has 6 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Azora Therapeutics, Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Azora Therapeutics, Inc. stocks trade under the symbol AZR.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
AZR earnings for the last quarter are −11.25 USD per share, whereas the estimation was −1.03 USD, resulting in a −989.59% surprise. The estimated earnings for the next quarter are −0.30 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Azora Therapeutics, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Azora Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.

What it might mean:
– Stable demand: Sales are holding steady without clear growth or decline
– Mature business phase: Growth may be slowing in core segments
– Offsetting factors: Strength in some areas may be balancing weakness in others

What to look at next in Azora Therapeutics, Inc. financials:
– Margins: Profitability may improve or decline even if revenue is flat
– Net income & EPS: Cost control or share buybacks can still drive earnings changes
– Segment breakdown: Some business lines may be growing while others shrink
Yes, you can track Azora Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
AZR net income for the last quarter is ‪−51.99 M‬ USD, while the quarter before that showed ‪−2.02 M‬ USD of net income which accounts for ‪−2.47 K‬% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Azora Therapeutics, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Azora Therapeutics, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
AZR reached its all-time high of 5,900.00 USD on Jan 15, 2019. Its all-time low was 1.31 USD and was reached on May 15, 2026.

Explore the Azora Therapeutics, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 6.00 USD and 14.00 USD for AZR, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance